Mannkind Corporation MNKD
$3.90
+16.77%
at last close
Market Cap$1.25 billion
P/E Ratio—
Div Yield—
Volume15.02M
52-Week Range
$2.23$6.51
Analyst Ratings
- Consensus
- Buy — 6 Buy · 1 Hold · 0 Sell (7 analysts)
- Avg. Price Target
- $8.32 (+113.4% upside)
Key Stats
- Today's Range
- $3.30 – $4.03
- 50-Day Range
- $3.17 – $4.40
- 52-Week Range
- $2.23 – $6.51
- Volume
- 15.02 million shs
- Average Volume
- 4.16 million shs
- Market Cap
- $1.25 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 10.11%
- Days to Cover
- 9.59
About Mannkind Corporation
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Related Stocks
Compare head-to-head: MNKD vs LLY·MNKD vs JNJ·MNKD vs ABBV·MNKD vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.